🍃March issue out now!
New data on cardiac events in #COPD, septic shock, climate change and #TB, and much more
🔗 www.thelancet.com/issue/S2213-...
05.03.2026 08:59
👍 1
🔁 2
💬 0
📌 0
NEW VIEWPOINT—Paediatric rheumatology care in #Europe: setting children and adolescents into focus bit.ly/4cp7usm #Medsky #Rheumsky
03.03.2026 10:45
👍 0
🔁 0
💬 0
📌 0
Attending the World Congress on #SystemicSclerosis in Athens next week?
Anna Clark, Editor-in-Chief, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
27.02.2026 12:17
👍 0
🔁 0
💬 0
📌 0
Attending the #EuropeanLupusMeeting in Lisbon next week?
Aisling O'Brien, Acting Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
25.02.2026 14:39
👍 0
🔁 0
💬 0
📌 0
Our March 2026 issue is live!
Including research in individuals at risk of developing arthritis, real-world data on anifrolumab in #SLE, #cardiovascular risk in #APS, and childhood-onset Sjögren's disease, plus much more! thelancet.com/journals/lan... #Rheumsky
Cover by @emma-cheng.bsky.social
24.02.2026 14:57
👍 3
🔁 4
💬 0
📌 0
NEW RESEARCH—Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study bit.ly/4bZ4dQe @uspoficial.bsky.social
Plus linked Comment bit.ly/3MzdOD4
#Medsky #Rheumsky
20.02.2026 09:35
👍 1
🔁 1
💬 0
📌 0
NEWS—Frailty care in England deemed deficient
bit.ly/4qFV16O #Medsky #Rheumsky
17.02.2026 17:51
👍 1
🔁 0
💬 0
📌 0
Fiona Pearce and Rachel Tattersall on HLH mortality rates in Europe
Podcast Episode · The Lancet Rheumatology in conversation with · 01/26/2026 · 35m
NEW podcast episode🎧
Acting Deputy Editor, Aisling O'Brien, talks to Fiona Pearce & Rachel Tattersall about #HLH mortality rates in Europe
Listen now
Apple: bit.ly/3Off8LR
Spotify: bit.ly/3OFqGYM
Full Article: bit.ly/4p5f9hT
#Medsky #Rheumsky
13.02.2026 14:06
👍 0
🔁 1
💬 0
📌 0
Announcing The Lancet Medical Imaging & Theranostics. A new open access journal dedicated to clinical and technological advances in radiology, neuclear medicine, and theranostics. Artwork: Abstract medical image of a torso with vibrant organic shapes and geometric patterns, suggesting medical imaging. Credit: Shonagh Rae
🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics!
Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0
#medsky
05.02.2026 17:29
👍 7
🔁 13
💬 0
📌 0
NEW RESEARCH—Patient profiles and early response in patients with systemic #lupus erythematosus initiating #anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study bit.ly/4aj9YWz
Plus, linked Comment bit.ly/3ZliHT6
#Medsky #Rheumsky #SLE
06.02.2026 16:26
👍 2
🔁 0
💬 0
📌 0
Since their introduction 20 years ago, GLP-1 receptor agonists have revolutionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi
#Medsky #Rheumsky
04.02.2026 13:48
👍 1
🔁 1
💬 0
📌 0
NEW REVIEW—The path to interception in psoriatic disease: from conceptual clarity to clinical translation
bit.ly/3ZD1NPE #Medsky #Rheumsky
29.01.2026 16:07
👍 0
🔁 0
💬 0
📌 0
Our Feb 2026 issue is live!
Including total versus partial knee replacement, vagus nerve stimulation in hand #OA, mortality due to #HLH, #pregnancy outcomes in #vasculitis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky
Cover art by @emma-cheng.bsky.social
27.01.2026 09:53
👍 0
🔁 0
💬 0
📌 0
NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq
Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky
21.01.2026 09:55
👍 0
🔁 2
💬 0
📌 0
NEW RESEARCH—Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial bit.ly/4pKm4xD #Medsky #Rheumsky
20.01.2026 17:32
👍 0
🔁 0
💬 0
📌 0
John Isaacs and Josh Bennett on sarcopenia in rheumatoid arthritis
Podcast Episode · The Lancet Rheumatology in conversation with · 12/15/2025 · 19m
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to John Isaacs & Josh Bennett about #sarcopenia and the RAMUS study, which looked at the skeletal muscle effects tofacitinib in #RA
Apple: bit.ly/49fUy6d
Spotify: bit.ly/3YSXxeC
Full Article: bit.ly/45tQXPn
#Medsky #Rheumsky
05.01.2026 10:34
👍 2
🔁 1
💬 0
📌 0
Workers demolish the facade of the East Wing of the White House on October 20, 2025 in Washington, DC. Copyright: Kevin Dietsch/Getty Images.
"the most disastrous year for US public health policy"
The US faces a critical public health crossroads as recent policy shifts threaten decades of progress.
What are the implications for future health security and scientific integrity?
Our Editorial: spkl.io/63326AcVQy
19.12.2025 14:33
👍 10
🔁 11
💬 0
📌 1
NEW Viewpoint—Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits bit.ly/4apjdGd #Medsky #Rheumsky
19.12.2025 12:13
👍 2
🔁 0
💬 0
📌 0
Crude mortality rates of haemophagocytic lymphohistiocytosis by age and sex in Europe (2011–21). Bars are 95% CI.
NEW RESEARCH—Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study bit.ly/4p5f9hT #HLH @racheltattersall.bsky.social
18.12.2025 14:23
👍 1
🔁 1
💬 0
📌 0
EBV and #SLE: causal or concurrence?
Read our Jan 2026 editorial bit.ly/49hm6I4
#Medsky #Rheumsky
17.12.2025 17:41
👍 1
🔁 2
💬 0
📌 0
Our Jan 2026 issue is live!
Including #RheumatoidArthritis, #IgG4-related disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
#Medsky #Rheumsky
And introducing our cover artist for 2026, Emma Cheng @emma-cheng.bsky.social
16.12.2025 10:02
👍 2
🔁 0
💬 0
📌 0
NEW REVIEW—Skin cancer in inflammatory arthritis: should we advise screening? bit.ly/3MsvsIc #Medsky #Rheumsky
10.12.2025 17:28
👍 1
🔁 0
💬 0
📌 0
NEW RESEARCH—Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study
bit.ly/4rCIa77 #Medsky #Rheumsky
04.12.2025 16:14
👍 1
🔁 1
💬 0
📌 0
Oxford Knee Score over time
NEW RESEARCH—Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial bit.ly/4pAMZMq #Medsky #Rheumsky #Orthosky
28.11.2025 14:33
👍 2
🔁 2
💬 0
📌 0
Our December issue is live!
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
18.11.2025 15:16
👍 3
🔁 0
💬 0
📌 0
Recommendations for the treatment of rheumatoid arthritis in Latin America
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
13.11.2025 15:00
👍 2
🔁 1
💬 0
📌 0
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
06.11.2025 15:42
👍 2
🔁 3
💬 0
📌 0
Our December issue is out now at www.thelancet.com/journals/lan...
Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more!
#GastroSky #LiverSky #MedSky
06.11.2025 06:57
👍 1
🔁 3
💬 0
📌 0
